Sunday, September 29, 2019

New Data Demonstrate Strong Outcomes for Abbott Device to Repair Leaky Tricuspid Heart Valves

SAN FRANCISCO, Sept. 28, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new data that suggest Abbott's investigational TriClip™ device may offer physicians an effective minimally invasive repair option for patients suffering from a leaky tricuspid valve, a condition also known as...



from PR Newswire: https://ift.tt/2lXprqZ

No comments:

Post a Comment